Microtubule re-organization during female meiosis in C elegans
- Technische Universitaet Dresden, Germany
- University of California, Santa Barbara, United States
- University of Virginia, United States
- Zuse Institute Berlin, Germany
- University of Alberta, Canada
- Flatiron Institute, United States
Abstract
The female meiotic spindles of most animals are acentrosomal and undergo striking morphological changes while transitioning from metaphase to anaphase. The ultra-structure of acentrosomal spindles, and how changes to this structure correlate with such dramatic spindle rearrangements remains largely unknown. To address this, we applied light microscopy, large-scale electron tomography and mathematical modeling of female meiotic C. elegans spindles undergoing the transition from metaphase to anaphase. Combining these approaches, we find that meiotic spindles are dynamic arrays of short microtubules that turn over on second time scales. The results show that the transition from metaphase to anaphase correlates with an increase in the number of microtubules and a decrease in their average length. Detailed analysis of the tomographic data revealed that the length of microtubules changes significantly during the metaphase-to-anaphase transition. This effect is most pronounced for those microtubules located within 150 nm of the chromosome surface. To understand the mechanisms that drive this transition, we developed a mathematical model for the microtubule length distribution that considers microtubule growth, catastrophe, and severing. Using Bayesian inference to compare model predictions and data, we find that microtubule turn-over is the major driver of the observed large-scale reorganizations. Our data suggest that in metaphase only a minor fraction of microtubules, those that are closest to the chromosomes, are severed. The large majority of microtubules, which are not in close contact with chromosomes, do not undergo severing. Instead, their length distribution is fully explained by growth and catastrophe alone. In anaphase, even microtubules close to the chromosomes show no signs of cutting. This suggests that the most prominent drivers of spindle rearrangements from metaphase to anaphase are changes in nucleation and catastrophe rate. In addition, we provide evidence that microtubule severing is dependent on the presence of katanin.
Data availability
Electron microscopy models of microtubules and chromosome surfaces will be made available on Dryad under doi.org/10.5061/dryad.x3ffbg7k5. Example data and analysis code is available at https://github.com/SebastianFuerthauer/SpindleRerrangement
-
C. elegans meiotic spindlesDryad Digital Repository, doi.org/10.5061/dryad.x3ffbg7k5.
-
Meiosis I spindles of Metaphase, early Anaphase and Anaphasehttps://www.cell.com/current-biology/fulltext/S0960-9822(18)30911-4?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0960982218309114%3Fshowall%3Dtrue.
Article and author information
Author details
Funding
Deutsche Forschungsgemeinschaft (MU 1423/3-1)
- Ina Lantzsch
Deutsche Forschungsgemeinschaft (MU 1423/3-2)
- Ina Lantzsch
Deutsche Forschungsgemeinschaft (MU 1423/8-1)
- Erik Szentgyoergyi
Technische Universität Darmstadt (Frauenhabilitation)
- Stefanie Redemann
Natural Sciences and Engineering Research Council of Canada
- Martin Srayko
National Science Foundation (DMR-0820484)
- Che-Hang Yu
National Science Foundation (NeuroNex #1934288)
- Che-Hang Yu
National Institutes of Health (1R01GM104976-01)
- Che-Hang Yu
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Thomas Surrey, Centre for Genomic Regulation (CRG), Spain
Version history
- Received: May 14, 2020
- Accepted: May 24, 2021
- Accepted Manuscript published: June 11, 2021 (version 1)
- Version of Record published: June 24, 2021 (version 2)
- Version of Record updated: February 23, 2023 (version 3)
Copyright
© 2021, Lantzsch et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,366
- views
-
- 305
- downloads
-
- 13
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Microtubule re-organization during female meiosis in C elegans
eLife 10:e58903.
https://doi.org/10.7554/eLife.58903
Further reading
-
- Cancer Biology
- Cell Biology
Immune checkpoint inhibitors have produced encouraging results in cancer patients. However, the majority of ß-catenin-mutated tumors have been described as lacking immune infiltrates and resistant to immunotherapy. The mechanisms by which oncogenic ß-catenin affects immune surveillance remain unclear. Herein, we highlighted the involvement of ß-catenin in the regulation of the exosomal pathway and, by extension, in immune/cancer cell communication in hepatocellular carcinoma (HCC). We showed that mutated ß-catenin represses expression of SDC4 and RAB27A, two main actors in exosome biogenesis, in both liver cancer cell lines and HCC patient samples. Using nanoparticle tracking analysis and live-cell imaging, we further demonstrated that activated ß-catenin represses exosome release. Then, we demonstrated in 3D spheroid models that activation of β-catenin promotes a decrease in immune cell infiltration through a defect in exosome secretion. Taken together, our results provide the first evidence that oncogenic ß-catenin plays a key role in exosome biogenesis. Our study gives new insight into the impact of ß-catenin mutations on tumor microenvironment remodeling, which could lead to the development of new strategies to enhance immunotherapeutic response.
